Micro-X Limited

ASX:MX1 Stock Report

Market Cap: AU$39.0m

Micro-X Valuation

Is MX1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MX1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MX1's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MX1's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MX1?

Key metric: As MX1 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MX1. This is calculated by dividing MX1's market cap by their current revenue.
What is MX1's PS Ratio?
PS Ratio2.6x
SalesAU$15.22m
Market CapAU$38.97m

Price to Sales Ratio vs Peers

How does MX1's PS Ratio compare to its peers?

The above table shows the PS ratio for MX1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.3x
CDX CardieX
2.5x54.8%AU$32.4m
EYE Nova Eye Medical
1.5x26.3%AU$35.5m
RHT Resonance Health
2.8xn/aAU$24.4m
CVB CurveBeam AI
6.4x45.9%AU$41.4m
MX1 Micro-X
2.6x38.2%AU$39.5m

Price-To-Sales vs Peers: MX1 is good value based on its Price-To-Sales Ratio (2.6x) compared to the peer average (3.3x).

Price to Sales Ratio vs Industry

How does MX1's PS Ratio compare vs other companies in the AU Medical Equipment Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
SDI SDI
1.1x5.4%US$79.03m
SOM SomnoMed
0.6x9.0%US$34.51m
CMP Compumedics
1xn/aUS$34.05m
NXS Next Science
1.2x30.6%US$27.14m
MX1 2.6xIndustry Avg. 3.1xNo. of Companies11PS0612182430+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MX1 is good value based on its Price-To-Sales Ratio (2.6x) compared to the Australian Medical Equipment industry average (3.1x).

Price to Sales Ratio vs Fair Ratio

What is MX1's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MX1 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.6x
Fair PS Ratio2.8x

Price-To-Sales vs Fair Ratio: MX1 is good value based on its Price-To-Sales Ratio (2.6x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SDI

AU$122.4m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

SDI

AU$1.02

7D

0%

1Y

22.9%

Doctor Care Anywhere Group

AU$25.7m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.065

7D

-3.0%

1Y

32.7%

Nova Eye Medical

AU$36.6m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

EYE

AU$0.16

7D

3.2%

1Y

14.3%